Oxtox is bringing technology to the drugs of abuse testing market. With a focus on roadside, transport and heavy industry testing, it is using novel electrochemistry to provide cost effective solutions where speed and accuracy are essential for safety.
As at 30 June 2011 |
IP Group holding |
|
23.7% |
|
Holding represents undiluted beneficial equity interest excluding debt